Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

17.95
+0.64003.70%
Pre-market: 17.66-0.2900-1.62%04:49 EDT
Volume:8.18M
Turnover:146.27M
Market Cap:14.32B
PE:-16.06
High:18.33
Open:17.10
Low:16.98
Close:17.31
52wk High:29.23
52wk Low:12.07
Shares:797.75M
Float Shares:154.32M
Volume Ratio:1.10
T/O Rate:5.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1177
EPS(LYR):-1.4439
ROE:-192.50%
ROA:-101.61%
PB:22.73
PE(LYR):-12.43

Loading ...

UK Car Production Rises 5.7% in August

Deep News
·
Sep 30

FTSE 100 Hits Two-Week Low as Energy Stocks Slide

Reuters
·
Sep 30

Unusually active option classes on open September 29th

TIPRANKS
·
Sep 29

Movement Alert|Summit Therapeutics PLC Rises 18.98% in Regular Trading, AstraZeneca Invests $2 Billion to Deepen Ivonescimab Collaboration

Market Focus
·
Sep 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 29

Leerink Partners Sticks to Its Hold Rating for Summit Therapeutics (SMMT)

TIPRANKS
·
Sep 29

Premarket: Nasdaq Futures Rise 0.45% as Traders Eye Trump AI Luncheon

Deep News
·
Sep 29

US Stocks-US Stock Futures Tick Higher as Tech Steadies Though Oil, Yields Stay High

Reuters
·
Sep 29

Top Premarket Gainers

MT Newswires Live
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Ocular Therapeutix (OCUL) and Regeneron (REGN)

TIPRANKS
·
Sep 29

AstraZeneca Strikes Clinical Collaboration with Summit to Test ADC Sonesitatug Vedotin with Ivonescimab in GI Cancers

Reuters
·
Sep 29

AMD, Nvidia, Navitas, Summit Therapeutics, Fair Isaac, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 29

FTSE 100 Rises as AstraZeneca Lifts Healthcare Sector

Reuters
·
Sep 29

AstraZeneca Dips Toes in Emerging Class of Cancer Drugs

Dow Jones
·
Sep 29

SMMT Rises 24% in Pre-Market Trading, AstraZeneca Invests $2 Billion to Deepen Ivonescimab Collaboration

Market Focus
·
Sep 29

US Research Roundup-Acuity, Dell Technologies, Nike

Reuters
·
Sep 29

AstraZeneca Shares up 2% to Two-Month High After Summit Therapeutics Investment

THOMSON REUTERS
·
Sep 29

AstraZeneca: Each Co Will Retain Development and Commercial Rights to Their Respective Medicines

THOMSON REUTERS
·
Sep 29

AstraZeneca Broadens Oncology Portfolio Through Summit Deal

Dow Jones
·
Sep 29

Toyota Land Cruiser 2026: Old-school 4×4 ready for anything

cityam
·
Sep 29